The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Incyte; Novartis
Consulting or Advisory Role - Sun Pharma
Speakers' Bureau - Incyte; Novartis
Research Funding - Incyte
Travel, Accommodations, Expenses - Incyte; Novartis
An independent review of arterial occlusive events (AOEs) in the ponatinib (PON) phase II PACE trial (NCT01207440) in patients (pts) with Ph+ leukemia.
 
James L Januzzi
Research Funding - Abbott Laboratories (Inst); Prevencio (Inst); Roche (Inst); Siemens Healthcare Diagnostics (Inst)
 
Joseph Garasic
Employment - Vertex (I)
Stock and Other Ownership Interests - Vertex (I)
Consulting or Advisory Role - Abbvie; ACI Clinical; Baim Institute for Clinical Research; Parexel
Research Funding - ReCor Medical
 
Scott Kasner
Other Relationship - Takeda
 
Vickie McDonald
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Amgen; Bayer; Novartis; Takeda
Research Funding - Novartis; Rigel
 
Mark C Petrie
Other Relationship - Takeda
 
Jonathan Seltzer
Employment - WIRB-Copernicus Group
Leadership - WIRB-Copernicus Group
Stock and Other Ownership Interests - WIRB-Copernicus Group
 
Michael J. Mauro
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
 
Kevin Croce
No Relationships to Disclose
 
Ellin Berman
Consulting or Advisory Role - Astellas Pharma; Takeda
 
Michael W.N. Deininger
Honoraria - ARIAD; Blueprint Medicines; Bristol-Myers Squibb; Galena Biopharma; Incyte; Novartis; Pfizer
Consulting or Advisory Role - Adelphi; ARIAD; Ascentage Pharma; Blueprint Medicines; Fusion Pharmaceuticals; Galena Biopharma; Humana; Incyte; Incyte; Medscape; Novartis; Pfizer; Sangamo Therapeutics; Takeda; TRM Oncology; TRM Oncology
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - ARIAD; Blueprint Medicines; Galena Biopharma; Incyte; Novartis; Pfizer
 
Andreas Hochhaus
No Relationships to Disclose
 
Javier Pinilla-Ibarz
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen; Novartis; Takeda; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; Janssen; Takeda
Research Funding - MEI Pharma; Sunesis Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Sellas Life Sciences
 
Franck E. Nicolini
No Relationships to Disclose
 
Dong-Wook Kim
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Pfizer; Sun Pharma; Takeda
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Immunogen; Incyte; Novartis; Pfizer; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
 
Jing Xu
Employment - Takeda
 
Shouryadeep Srivastava
Employment - Takeda
 
Daniel Naranjo
Employment - Takeda
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)